Biosynthesis of 3-iodothyronamine from T4 in murine intestinal tissue

Endocrinology (United States)

Volumn 156, Issue 11, 2015, Pages 4356-4364

  Hoefig, Carolin S ^a,b   Wuensch, Tilo ^b,c   Rijntjes, Eddy ^a   Lehmphul, Ina ^a   Daniel, Hannelore ^c   Schweizer, Ulrich ^a,d   Mittag, Jens ^b,e   Köhrle, Josef ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF BONN   (Germany)

^e UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 IODOTHYRONAMINE; AMINE; ORNITHINE DECARBOXYLASE; PERCHLORATE; THIAMAZOLE; THYROID HORMONE; THYROXINE; UNCLASSIFIED DRUG; 3-IODOTHYRONAMINE; IODIDE PEROXIDASE; IODOTHYRONINE DEIODINASE TYPE I; IODOTHYRONINE DEIODINASE TYPE II; THYRONINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; DECARBOXYLATION; DEIODINATION; GENE EXPRESSION; GENETIC ANALYSIS; HYPOTHYROIDISM; INTESTINAL TISSUE; INTESTINE ABSORPTION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; VALIDITY; ANIMAL; INTESTINE; METABOLISM;

ANIMALS; INTESTINES; IODIDE PEROXIDASE; MICE; THYRONINES; THYROXINE;

EID: 84946039854     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1499     Document Type: Article

References (33)

1. Cheng SY, Leonard JL, Davis PJ. Molecular aspects of thyroid hormone actions. Endocr Rev. 2010;31:139-170.
2. Brent GA. Mechanisms of thyroid hormone action. J Clin Invest. 2012;122:3035-3043.
3. Dratman MB. On the mechanism of action of thyroxin, an amino acid analog of tyrosine. J Theor Biol. 1974;46:255-270.
4. Scanlan TS, Suchland KL, Hart ME, et al. 3-Iodothyronamine is an endogenous and rapid-Acting derivative of thyroid hormone. Nat Med. 2004;10:638-642.
5. Hackenmueller SA, Marchini M, Saba A, Zucchi R, Scanlan TS. Biosynthesis of 3-iodothyronamine (T1AM) is dependent on the sodium-iodide symporter and thyroperoxidase but does not involve extrathyroidal metabolism of T4. Endocrinology. 2012;153:5659-5667.
6. Hoefig CS, Renko K, Piehl S, et al. Does the aromatic L-Amino acid decarboxylase contribute to thyronamine biosynthesis? Mol Cell Endocrinol. 2012;349:195-201.
7. Ackermans MT, Klieverik LP, Ringeling P, Endert E, Kalsbeek A, Fliers E. An online solid-phase extraction-liquid chromatography-tandem mass spectrometry method to study the presence of thyro-namines in plasma and tissue and their putative conversion from 13C6-thyroxine. J Endocrinol. 2010;206:327-334.
8. Hoefig CS, Köhrle J, Brabant G, et al. Evidence for extrathyroidal formation of 3-iodothyronamine in humans as provided by a novel monoclonal antibody-based chemiluminescent serum immunoassay. J Clin Endocrinol Metab. 2011;96:1864-1872.
9. Piehl S, Hoefig CS, Scanlan TS, Köhrle J. Thyronamines-past, present, and future. Endocr Rev. 2011;32:64-80.
10. Braulke LJ, Klingenspor M, DeBarber A, et al. 3-Iodothyronamine: a novel hormone controlling the balance between glucose and lipid utilisation. J Comp Physiol B. 2008;178:167-177.
11. Saba A, Chiellini G, Frascarelli S, et al. Tissue distribution and cardiac metabolism of 3-iodothyronamine. Endocrinology. 2010;151: 5063-5073.
12. Agretti P, De Marco G, Russo L, et al. 3-Iodothyronamine metabolism and functional effects in FRTL5 thyroid cells. J Mol Endocrinol. 2011;47:23-32.
13. Alam MA, Al-Jenoobi FI, Al-Mohizea AM. Everted gut sac model as a tool in pharmaceutical research: limitations and applications. J Pharm Pharmacol. 2012;64:326-336.
14. Wuensch T, Schulz S, Ullrich S, et al. The peptide transporter PEPT1 is expressed in distal colon in rodents and humans and contributes to water absorption. Am J Physiol Gastrointest Liver Physiol. 2013; 305:G66-G73.
15. Piehl S, Heberer T, Balizs G, et al. Thyronamines are isozyme-spe-cific substrates of deiodinases. Endocrinology. 2008;149:3037-3045.
16. Leonard JL, Rosenberg IN. Iodothyronine 5'-deiodinase from rat kidney: substrate specificity and the 5'-deiodination of reverse triiodothyronine. Endocrinology. 1980;107:1376-1383.
17. Köhrle J. Iodothyronine deiodinases. Methods Enzymol. 2002;347: 125-167.
18. Bassett JH, Boyde A, Howell PG, et al. Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts. Proc Natl Acad Sci USA. 2010;107:7604-7609.
19. Sabatino L, Iervasi G, Ferrazzi P, Francesconi D, Chopra IJ. A study of iodothyronine 5'-monodeiodinase activities in normal and pathological tissues in man and their comparison with activities in rat tissues. Life Sci. 2000;68:191-202.
20. Iwami K, Wang JY, Jain R, McCormack S, Johnson LR. Intestinal ornithine decarboxylase: half-life and regulation by putrescine. Am J Physiol. 1990;258:G308-G315.
21. López-Contreras AJ, de la Morena ME, Ramos-Molina B, Lamber-tos A, Cremades A, Penafiel R. The induction of cardiac ornithine decarboxylase by/32-Adrenergic agents is associated with calcium channels and phosphorylation of ERK1/2. J Cell Biochem. 2013; 114:1978-1986.
22. Passariello CL, Gottardi D, Cetrullo S, et al. Evidence that AMP-Activated protein kinase can negatively modulate ornithine decarboxylase activity in cardiac myoblasts. Biochim Biophys Acta. 2012;1823:800-807.
23. Knopp J, Brtko J, Juráni M, Jaroscáková I, Jurcovicová J. Effect of 3, 5, 3'-L-triiodothyronine on hepatic ornithine decarboxylase and thymidine kinase activity in rat after partial hepatectomy. Endocr Regul. 1994;28:179-186.
24. Chiellini G, Frascarelli S, Ghelardoni S, et al. Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function. FASEB J. 2007;21:1597-1608.
25. Klieverik LP, Foppen E, Ackermans MT, et al. Central effects of thyronamines on glucose metabolism in rats. J Endocrinol. 2009; 201:377-386.
26. Ianculescu AG, Scanlan TS. 3-Iodothyronamine (T(1)AM): a new chapter of thyroid hormone endocrinology? Mol Biosyst. 2010;6: 1338-1344.
27. Lehmphul I, Brabant G, Wallaschofski H, et al. Detection of 3, 5-diiodothyronine in sera of patients with altered thyroid status using a new monoclonal antibody based chemiluminescence immunoassay. Thyroid. 2014;24:1350-1360.
28. Sandmeier E, Hale TI, Christen P. Multiple evolutionary origin of pyridoxal-5'-phosphate-dependent amino acid decarboxylases. Eur JBiochem. 1994;221:997-1002.
29. Musilli C, De Siena G, Manni ME, et al. Histamine mediates behavioral and metabolic effects of 3-iodothyroacetic acid (TA1), an endogenous end productofthyroid hormone metabolism. Br J Pharmacol. 2014;171:3476-3484.
30. Kern AD, Oliveira MA, Coffino P, Hackert ML. Structure of mammalian ornithine decarboxylase at 1. 6 A resolution: stereochemical implications of PLP-dependent amino acid decarboxylases. Structure. 1999;7:567-581.
31. Almrud JJ, Oliveira MA, Kern AD, Grishin NV, Phillips MA, Hack-ert ML. Crystal structure of human ornithine decarboxylase at 2. 1 A resolution: structural insights to antizyme binding. J Mol Biol. 2000;295:7-16.
32. Brix K, Fuhrer D, Biebermann H. Molecules important for thyroid hormone synthesis and action-known facts and future perspectives. Thyroid Res. 2011;4(suppl 1):S9.
33. Braun D, Wirth EK, Wohlgemuth F, et al. Aminoaciduria, but normal thyroid hormone levels and signalling, inmice lacking the amino acid and thyroid hormone transporter Slc7a8. Biochem J. 2011; 439:249-255.